So what's University of Utah President Taylor Randall doing at the BYU Creamery?
Friday's lunchtime crowd at Brigham Young University's iconic Creamery did a few double-takes when they spotted an unlikely guest sporting a Ute crimson red polo and enjoying a cone.
University of Utah President Taylor Randall took a quick break from a busy, three-day Southern Utah tour to indulge in his favorite BYU Creamery flavor: In-Shanely Chocolate — named, aptly, for his friend/rival/counterpart, BYU President C. Shane Reese.
But there was nothing cloak-and-dagger about Randall's lunch-hour reconnaissance deep inside Utah County.
Call it 'Ice Cream Diplomacy.'
The University of Utah leader and several members of his team were on campus Friday at the invitation of BYU leadership to enjoy burgers and sample the sugary Creamery goods.
But it also offered leaders from the two Utah schools — one private, one public — a few moments to fortify friendships and academic cooperation at a volatile moment for higher education.
'We have a lot of collaborations that go on between our two institutions — both formal and informal,' Randall told the Deseret News.
The two schools' respective claims, he added, are actually quite similar. 'There's probably more research collaborations going on between these two schools than you would even imagine, right at the professorial level.'
It's essential that those collaborations are accessible and maintained.
Both the University of Utah and BYU, Randall added, are entrusted with educating students in Utah. 'We share common concerns about how to increase individuals coming into the overall higher education system. So it's good to talk through what each other is seeing.'
Additionally, the two higher education institutions are working to solve basic societal problems.
'With BYU opening up a new medical school, and us expanding our medical school, one of our shared objectives is to solve access to healthcare issues in the Intermountain West — but also in the state of Utah, which ranks very, very low.'
Much of the University of Utah leadership's three-day Southern Utah tour focused on meeting with fellow educators and health care professionals to seek ways of improving medical care in rural communities.
BYU Administration Vice President and CFO Steve Hafen said he and his blue-clad associates were eager to host Randall and his team at a popular campus hang-out.
'It's an opportunity to sit down in a casual environment and get to know them a little bit better,' said Hafen. 'There's so much that they experience that we can relate that to — and so that collaboration and discussion is great.'
Hafen added his school continues to seek opportunities to strengthen relationships with Utah's flagship public university. 'The University of Utah is an outstanding educational institution with good leadership, and we want to learn from them. And I think they want to learn from us.'
'They're public. We're private. But there are a lot of synergies and a lot of things that we can collaborate on.'
Randall will return to the BYU campus on Oct. 18 to watch the Utes play the Cougars at LaVell Edwards Stadium.
And Hafen assured that the University of Utah leader will have his choice of Creamery flavors on that fast-approaching football Saturday. 'We'll leave the ice cream open all day long.'
Randall and his team Friday also toured the U.S. Army Reserves headquarters building project that's well underway at Camp Williams in Bluffdale.
Last August, the University of Utah and the U.S. Army Reserve announced a historic land transfer and relocation agreement.
Using more than $100 million appropriated by the Utah Legislature, the University of Utah is building a headquarters for the Army Reserve at Camp Williams, clearing the way for the military to vacate the remaining 50.9 acres it occupies just east of the university campus.
Following the relocation of the Army Reserve, the historic Fort Douglas property will be transferred to the University of Utah for future campus development.
The Utah Legislature appropriated a total of $117 million for a land purchase and to relocate the Utah Army National Guard 76th Operational Response Command's personnel and operations to Camp Williams.
Officials said Utah is the only state to fund such a military relocation.
The state of Utah will reportedly own the building and will lease it to the Army Reserve. Construction of the facility started in April of last year
Fort Douglas and the University of Utah have a shared history spanning more than 150 years.
According to a university press release, at one point, the fort stretched over 10,500 acres, from 900 South to 6th Avenue, and from 1300 East to the mouth of Emigration Canyon. Presently, the university surrounds the remaining 50 acres of fort property.
The new two-story, 215,000-square-foot Army Readiness Building at Camp Williams — which includes administrative offices, storage and a separate vehicle maintenance shop — is slated to open and begin operating in 2026.
The 50-acre Douglas Armed Forces Reserve Center at Fort Douglas has been constrained by outdated infrastructure, according to a university release.
The new site, contiguous to Camp Williams, will offer a modern, secure location with room for future expansion. It will support all current and future Army Reserve operations, providing a more efficient and accessible training environment.
The university had reportedly been working on the exchange for 14 years, annually submitting the proposal to the respective university presidents over that time as an institutional goal.
Following Friday's tour, Randall said the building projects' design and progress exceeds his 'wildest expectations.'
'It's exciting that two organizations could find and plot an exciting, joint future together,' he said. 'I give particular credit to state leaders for their vision in crafting a really unique interchange of property and buildings so that both of these great institutions could move forward.'
Even while touring the Camp Williams building project, Randall was considering the future of the Fort Douglas property on the university campus.
'We will start early-scenario planning over the next year of how we'll use that property,' he said. 'We already know the broad uses. Some of it will be for healthcare. The other piece will be for actually expanding our 'College Town Magic' to create a remarkable place for students to thrive.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Health Line
41 minutes ago
- Health Line
HIV: As Scientists Inch Closer to a Vaccine, Cuts to Funding Could Stall Progress
The Trump administration reportedly plans to cut almost all funding for HIV vaccine research. Experts say the decision comes at a time when research in this field is making substantial progress. Many effective treatments are available for HIV, but these are lifelong commitments that manage a chronic disease rather than cure it. Treatments for HIV infection have come a long way since the 1980s, when too many lives were lost during the epidemic. Today, antiretroviral therapies and other treatments allow people with HIV to live longer lives and, in many cases, prevent the transmission of the virus that causes the disease to other people. Scientists now say the next step in the fight is a vaccine that protects against HIV. However, that next development could be on the chopping block. Trump administration officials reportedly plan to halt funding for a wide array of HIV vaccine research. Researchers told CBS News they have been informed by officials at the National Institutes of Health (NIH) that the Department of Health and Human Services (HHS) has instructed the agency not to issue any more funding during the next fiscal year for HIV vaccine research. NIH officials said HHS officials have instead decided to 'go with currently available approaches to eliminate HIV.' The decision will close down HIV vaccine research projects at the Duke Human Vaccine Institute and the Scripps Research Institute, according to a report in the journal Science. Officials at Moderna also told CBS News that their current clinical trials on HIV vaccines have been put on hold. Experts say the decision to cut funding for an HIV vaccine is short-sighted and reckless. 'I'm stunned by this decision,' said Jake Scott, MD, a clinical associate professor of medicine at Stanford University in California who specializes in infectious diseases. 'There is no scientific or medical evidence to justify these cuts at the exact moment this field is showing real promise,' he told Healthline. Carl Baloney Jr., the chief executive officer-elect of AIDS United, agreed. 'Eliminating funding for HIV vaccine research undermines decades of scientific progress and turns our back on a future where HIV could be preventable for all, regardless of where someone lives, their income, or access to healthcare,' he told Healthline. Why an HIV vaccine is important Experts say that treatments for HIV are incredibly effective. However, they note that most involve daily adherence and aren't necessarily readily available or affordable for many people. 'There are a lot of good options, but they can be really expensive,' Scott said. 'These medications are also not a cure. They are a lifetime burden.' The experts add that people with low levels of HIV in their system can still have weakened immune systems. That can raise the risk of serious infections as well as inflammation that can lead to conditions such as heart disease. 'A vaccine can help prevent all this,' said Scott. Experts note that a vaccine research program may be difficult to put back together even if a new administration restored funding in the near future. They say it took decades to build these programs and restarting them would take time. In addition, researchers will leave the field of HIV prevention to set up shop in another industry that is receiving funding. 'We could lose an entire generation of scientists,' said Scott. 'This is setting the field back a decade or more at a critical time.' 'This isn't just about canceling [a] clinical trial. It's about sidelining the scientists, institutions, and community partners driving innovation forward,' added Baloney. 'These setbacks could delay the development of a successful HIV vaccine by years or even decades.' How scientists fought against HIV The first treatment for HIV was approved by the Food and Drug Administration (FDA) in 1987. Azidothymidine (AZT) was first developed in 1964 as a treatment for cancer. It was ineffective in that usage, but in the 1980s, scientists discovered AZT could suppress HIV replication without damaging healthy cells. It helped treat people with AIDS as well as people who were HIV positive but had no symptoms. In the 1990s, other nucleoside reverse transcriptase inhibitors (NRTIs) were developed and approved. Laboratory tests to measure viral load and cell counts accelerated this research. From there, scientists experimented with combining drugs to help counter the HIV virus's ability to mutate and replicate. In 1996, a triple-drug therapy proved effective in thwarting HIV replication and creating a barrier against drug resistance. Since then, these antiretroviral drugs have become more effective and more available. The effectiveness of these medications is nothing short of miraculous. In the 1980s, the average life expectancy after an AIDS diagnosis was one year. Today, people who adhere to combination antiretroviral drug therapies can expect to live a near-normal life span. In some cases, the medications can reduce the HIV viral load in a person to the point where the virus is undetectable and can't be transmitted to another person. How is HIV treated today? More than 50 types of HIV medications are now approved for use. Some of the more commonly used antiretroviral medications are: Combination NRTI drugs that include Truvada and Descovy. These medications work by preventing HIV from converting its RNA into DNA. This prevents the virus from making copies of itself.. Integrase strand transfer inhibitors (INSTIs) that include Vocabria and Biktarvy. These drugs work by blocking an enzyme that HIV uses to put HIV DNA into human DNA inside cells. Protease inhibitors (PIs) such as Lexiva and Crixivan. These medications work by blocking an enzyme that HIV needs as part of its life cycle. Non-nucleoside reverse transcriptase inhibitors (NNRTIs) that include Intelence and Viramune. These drugs work by preventing the HIV virus from making copies of itself. Entry inhibitors such as Fuzeon and Selzentry. These medications work by blocking HIV from entering CD4 T cells. In addition, there are drugs known as Cytochrome P4503A (CYP3A) inhibitors, such as Tybost and Norvir, that help boost the levels of HIV medications in the bloodstream. There are also medications known as post-attachment inhibitors that when used with antiretroviral drugs can help prevent HIV from entering immune cells. Trogarzo was the first of these drugs to become available, having been approved in 2018. In addition, there are attachment inhibitor medications, a newer form of HIV drug that works by attaching to a viral protein, which prevents that protein from entering healthy T cells. Only one type of this medication, Rubokia, is currently available, having been approved in 2020. Most people with HIV are given medications, but there also are long-acting injections that are given once a month or once every other month. Scott said these treatments are cures that have turned HIV into a 'managed chronic disease' to the point where he and other colleagues now refer to AIDS as 'advanced HIV.' Baloney said, however, there are limits to how much treatments can do. 'Current treatments and prevention tools have transformed HIV into a manageable chronic condition, but they are not a cure and they're not accessible to everyone,' he said. 'An HIV vaccine would be a game-changer, especially for communities facing systemic barriers to care.' Preventive measures for HIV Even with the available treatments, experts agree that it's better for a person if they don't contract HIV in the first place. They say condom use, along with dental dams and gloves, can be effective barriers to contracting HIV. Limiting sexual partners is also recommended, as are sterile needles for intravenous drug users. Getting tested for HIV is also an important component. It's estimated that more than 1 million people in the United States have HIV, and 13% of them don't know they have contracted the virus. There are medications available that can be taken as a precaution or after potential exposure to HIV. These drugs include: Preexposure prophylaxis (PrEP): These medications can be taken as a daily pill or a bimonthly injection. The first injectable PrEP drug was Apretude, which was approved by the FDA in 2021. Truvada can also be used as PrEP therapy. These medications help prevent HIV from getting a foothold in the body. Postexposure prophylaxis (PEP) drugs: These are designed to be taken within 72 hours of potential exposure to HIV. It is a pill ingested once a day for 28 days. Lenacapavir: This injectable drug has been tested in clinical trials as a potential PrEP therapy. The FDA is scheduled to vote on its approval on June 19. Experts say all these preventive measures are good practices, but they note that vaccines are still the most effective.
Forbes
43 minutes ago
- Forbes
6 Steps To Preserve Brain Health Now To Prevent Dementia As You Age
Scientists report that if you want to avoid dementia and Alzheimer's in later years, you must start ... More boosting and preserving your brain health in your twenties and thirties, instead of waiting until you're older. In honor of Brain Health Awareness this month, as the rates of Parkinson's, dementia and Alzheimer's are rising, I wondered what you can do early on to prevent these diseases. I found out that changes leading to neurodegenerative disease begin in your 20s and 30s. Most people don't realize that your brain doesn't suddenly age in your 60s or 70s. Now is the time to start promoting and preserving your brain health. The sooner you understand cognitive decline and what you can do to curb it now, the better your brain health will be in later years. If you can improve your brain health today, you'll reduce the risk of brain disease in the future, according to experts. I spoke by email with Dr. Rudolph Tanzi, a leading expert on Alzheimer's and neurodegenerative diseases. He is the Director of the Genetics and Aging Research Unit and the McCance Center for Brain health At Massachusetts General Hospital. Tanzi recommends that you talk with your primary care provider first and walk through the McCance Brain Care Score™-- the multi-dimensional brain care tracker to see where you stand today. Your score shows where you can improve your brain health. The brain health expert developed a plan to help you remember the everyday steps to take care of your brain now to preserve and promote brain health and prevent other age-related diseases, including heart disease, diabetes and cancer. Here is Tanzi's six-step SHIELD method with additional research that supports his plan. 1. S stands for sleep. Sleep deprivation hampers your ability to deal with stress. Tanzi emphasizes the importance of getting seven to eight hours of sleep each night. He says sleep serves to clear away the plaques that lead to cognitive decline, adding that plaques begin decades before signs of decline. So, getting good sleep at any age (even power naps) can improve your brain health. If you're looking for ways to improve the quality of your sleep, he suggests visiting The American Heart Association's guide to healthy sleep. 2. H is for handling stress. In six easy steps, meditation reduces cortisol levels by 25% and alters brain activity so you're less error prone and make fewer mistakes. Tanzi advises that you establish a meditation practice and manage expectations that can reduce stress. He recommends visiting the Benson-Henry Institute for Mind Body Medicine website for ongoing tips and guided meditations and the Mental Health & Well-being guide from The American Heart Association. 3. I is for interaction with friends. Tanzi points out that loneliness doubles the risk for Alzheimer's disease. In 2023, Dr. Vivek Murthy, the U.S. Surgeon General cited loneliness as a serious mental health hazard. Research shows that social connections improve your brain health. People with greater levels of social engagement have more robust gray matter in regions of the brain relevant in dementia. 4. E is for exercise. Regular exercise boosts heart rate and blood flow, which may help reduce the risk of cognitive decline. According to Tanzi, exercise induces new nerve cell growth to strengthen brain regions affected in Alzheimer's disease and triggers the breakdown of brain amyloid. He insists that finding an exercise that works for you is key. He recommends starting small and working up to the recommended 150 minutes per week, to have an impact on your brain health. 5. L is for learning new things. Your brain learns from novelty, which promotes adaptive learning by resetting key brain circuits and enhances your ability to update new ideas into existing neurological frameworks. 'Learning new things strengthens and increases the number of synapses in your brain, the connections between nerve cells storing your memories,' Tanzi states. 'Synapse loss correlates most with the degree of dementia. The more synapses you make, the more you have to spare. Puzzles aren't necessarily the answer, either.' He cites a recent Harvard Health article that concludes, 'Practicing a new and challenging activity is a good bet for building and maintaining cognitive skills.' He suggests that activities such as learning a new language or taking a class have major benefits for brain health. 6. D is for diet. Vitamin B is essential for brain wellness and can be found in eggs, whole grains, fish, avocados and citrus fruits. In Tanzi's opinion, the best diet for the brain is the Mediterranean diet, which minimizes red meat and is rich in fiber from fruit and vegetables. 'A plant based diet balances the bacteria in your gut, called the 'gut microbiome,' he points out. "A healthy gut microbiome has also been shown to reduce amyloid plaque and brain neuroinflammation, a major killer of nerve cells in the brain.' NAD+ (stands for nicotinamide adenine dinucleotide), a coenzyme critical to key cellular processes such as ATP production (converting food to energy in the cell), mitochondrial function and DNA repair. According to Dr. Andrew Shao, senior vice president of Global Scientific & Regulatory Affairs at Niagen Bioscience, it's essential to brain health because it supports neural health, powers cellular energy, repairs damaged DNA and activates a family of proteins that help regulate inflammation and protect neurons. Shao told me that NAD+ levels decline as we age (starting as early as our 30s) from stressors we face every day such as overeating, alcohol consumption, sun exposure, sedentary lifestyle and environmental pollutants. Shao adds that the decline in NAD+ impacts cellular repair and energy production, rendering the brain more vulnerable to neurodegeneration. He explains that the most effective way to support your NAD+ levels is with a form of vitamin B3 (nicotinamide riboside or NR). He notes that 1000mg of the oral supplement Niagen is a safe and effective supplement of vitamin B3 that restores NAD+ levels by up to 150%, supporting the cellular processes that keep your brain healthy and resilient as the levels decline with age. Shao concludes that researchers are uncovering the potential of elevating NAD+ in people with Parkinson's and Alzheimer's. He reports that early findings show potential to improve brain metabolism and reduce neuroinflammation. In addition to the SHIELD method, Shao suggests that you can support mitochondrial health with supplements of NR, starting in your early 30s to support brain health over time.
Yahoo
an hour ago
- Yahoo
ThinkCareBelieve: Week 21 of America's Progress under President Trump
Washington D.C., June 14, 2025 (GLOBE NEWSWIRE) -- You can find the article here: has published an article on the 21st week of America under the leadership of President Donald J. Trump. America is making strong progress toward prosperity and ThankCareBelieve's article shows this weeks numbers and indicators supporting that. Prices are going down. Tariffs are working. Inflation is gone. The economy is strong and once the One Big Beautiful Bill is passed, the economy will be booming. The article has a report by Maria Bartiromo that the CPI (Consumer Price Index) is out and the numbers are better than expected, surprising everyone. The trade deal with China is now complete, allowing China's markets to open up for American products which will help American business soar. The article shows this week's Los Angeles riots have sparked several investigations where they actually were paid anarchy by those wanting to disrupt American 21st week ends on Flag Day, the 25th Anniversary of the U.S. Army and the Birthday of President Donald J. Trump. The article shows how strong America has become with record number of enlistments and re-enlistments, President Trump attended an Invest in America Event and the President signing an end to costly and impractial EV Mandates. The Halt Fentanyl Act has been passed and is ready to be signed. The article also covers Secretary Kennedy's huge steps to restore public trust by appointing a new board to the Advisory Committee for Immunization Practices (ACIP), including the appointment of Dr. Robert Malone, M.D. is an outlook. ThinkCareBelieve's mission for Peace advocacy facilitates positive outcomes and expanded possibilities. To achieve Peace, we will find the commonalities between diverse groups and bring the focus on common needs, working together toward shared goals. Activism is an important aspect of ThinkCareBelieve, because public participation and awareness to issues needing exposure to light leads to justice. Improved transparency in government can lead to changes in policy and procedure resulting in more fluid communication between the public and the government that serves them. America needs hope right now, and Americans need to be more involved in their government. ### CONTACT: CONTACT: Joanne COMPANY: ThinkCareBelieve EMAIL: joanne@ WEB: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
